{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464387333
| IUPAC_name = ''N''-<nowiki>[[</nowiki>2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]-''N''-methylbutanamide
| image = Saripidem.svg
| width = 222

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 103844-86-6
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 3058746
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2319846
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0J6174G60N
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 73416

<!--Chemical data-->
| C=19 | H=20 | Cl=1 | N=3 | O=1 
| molecular_weight = 341.835 g/mol
| smiles = O=C(N(C)Cc1c(nc2ccccn12)c3ccc(Cl)cc3)CCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H20ClN3O/c1-3-6-18(24)22(2)13-16-19(14-8-10-15(20)11-9-14)21-17-7-4-5-12-23(16)17/h4-5,7-12H,3,6,13H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = LIFDPEORUVTOCP-UHFFFAOYSA-N
}}

'''Saripidem''' is a [[sedative]] and [[anxiolytic]] drug in the [[imidazopyridine]] family, which is related to the better known drugs [[zolpidem]] and [[alpidem]]. 

Saripidem has a similar pharmacological profile to the [[benzodiazepine]] family of drugs including sedative and anxiolytic properties, but its [[chemical structure]] is quite different from that of the benzodiazepine drugs, and saripidem is described as a [[nonbenzodiazepine]]. 

The mechanism of action by which saripidem produces its sedative and anxiolytic effects is by modulating the benzodiazepine binding site on [[GABAA receptor|GABA<sub>A</sub>]] receptors, however unlike many older GABA<sub>A</sub> [[agonist]]s, saripidem is highly subtype selective and binds primarily to the ω1 subtype.<ref name="pmid11224318">{{cite journal | author = Sanger DJ | title = Behavioural effects of novel benzodiazepine (omega) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue | journal = Behavioural Pharmacology | volume = 6 | issue = 2 | pages = 116–126 | year = 1995 | pmid = 11224318 | doi = 10.1097/00008877-199503000-00003| issn = }}</ref>

==References==
<references/>

{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Carboxamides]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Imidazopyridines]]
[[Category:Sedatives]]